Azzad Asset Management Inc /Adv Horizon Therapeutics Public LTD CO Transaction History

Azzad Asset Management Inc /Adv

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Apr 01, 2024	SELL	$62.39 - $113.8 $1.43 Million - $2.6 Million	-22,856 Closed	0 $0
Q3 2022 Apr 01, 2024	BUY	$58.92 - $84.67 $185,362 - $266,371	3,146 Added 15.96%	22,856 $1.41 Billion
Q2 2022 Apr 01, 2024	BUY	$79.4 - $116.36 $48,831 - $71,561	615 Added 3.22%	19,710 $1.57 Billion
Q1 2022 Apr 01, 2024	BUY	$86.42 - $109.81 $218,556 - $277,709	2,529 Added 15.27%	19,095 $2.01 Billion
Q4 2021 Apr 01, 2024	SELL	$98.56 - $119.91 $10,053 - $12,230	-102 Reduced 0.61%	16,566 $1.79 Billion

Q3 2021 Apr 01, 2024	BUY	$91.91 - $110.37 $91 - $110	1 Added 0.01%	16,668 $1.83 Billion
Q2 2021 Apr 01, 2024	SELL	$86.24 - $95.92 $86 - $95	-1 Reduced 0.01%	16,667 $1.56 Billion
Q1 2021 Apr 01, 2024	BUY	$71.83 - $95.48 $1.2 Million - $1.59 Million	16,668 New	16,668 $1.53 Billion

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.